publication date: Feb. 7, 2014
20140207 - Feb. 7, 2014
ISSUE 6 – FEB. 7, 2014PDF

“Confidential and Proprietary” Document Proposes Plan for National Network

You might think of this as an event isolated to Columbus or central Ohio: 

On Feb. 7, OhioHealth, a health system that operates not-for-profit, faith-based hospitals in central Ohio and competes with Ohio State University, said it would join the outreach network of MD Anderson Cancer Center, located almost 1,200 miles away.

photoConversation with The Cancer Letter 
McKinsey Charge: Create Plan 
To Expand MD Anderson’s Reach

Responding to questions from The Cancer Letter, Jim Newman, director of external communications at MD Anderson, confirmed that the presentation obtained by The Cancer Letter was prepared under a contract by McKinsey & Company.

photoCVS to Stop Tobacco Sales at Pharmacies

CVS Caremark plans to stop selling cigarettes and other tobacco products at more than 7,600 CVS/pharmacy stores by Oct. 1.

The country’s largest drug store chain in overall sales estimated that it will forego approximately $2 billion—about 17 cents per share—in revenues on an annual basis from snuffing out Big T.

photoDrug Development
Tivozanib Trial Discontinued Due to Insufficient Enrollment

AVEO Oncology and Astellas Pharma Inc. discontinued a phase II study of tivozanib in locally recurrent or metastatic triple-negative breast cancer due to insufficient enrollment.

photoIn Brief

  • Wendy Selig elected president Of NCCR board of directors

  • Dana-Farber Receives $900,000 for ovarian cancer research

  • Richard Folkers named director of communications for the Foundation for the NIH

  • Sarah Cannon to integrate cancer programs with HealthONE hospitals

  • Amgen and Merck to collaborate on oncolytic immunotherapy

  • Univ. of Pittsburgh selects GenomAnalytics platform for TGCA data

  • Health Canada approves Aptima HPV assay

  • Definiens and Clarient sign agreement over image analysis software

Copyright (c) 2019 The Cancer Letter Inc.